You can now submit reviews for your favorite Tocris products. Your review will help other researchers decide on the best products for their research. Why not submit a review today?!Submit Review
Biological Activity for Molnupiravir
Molnupiravir is a broad-spectrum antiviral prodrug of the nucleoside analog β-D-N4-hydroxycytidine (NHC). Molnupiravir competes predominantly with CTP for incorporation; it induces lethal viral mutagenesis by increasing G to A and C to U transition mutations without inhibition of RNA synthesis in replicating coronaviruses, which prevents the development of viral resistance. In primary airway epithelial cell cultures, Molnupiravir dose-dependently inhibits SARS-CoV-2 infectious virus production; it also inhibits MERS-CoV and SARS-CoV with EC50 values in the submicromolar range. In mice infected with SARS-CoV or MERS-CoV, Molnupiravir improves pulmonary function, and reduces virus titer and body weight loss. Molnupiravir also displays in vivo efficacy against seasonal and pandemic influenza A shed virus. It is orally bioavailable.
Technical Data for Molnupiravir
|Storage||Store at -20°C|
The technical data provided above is for guidance only. For batch specific data refer to the Certificate of Analysis.
Tocris products are intended for laboratory research use only, unless stated otherwise.
Solubility Data for Molnupiravir
|Solvent||Max Conc. mg/mL||Max Conc. mM|
Preparing Stock Solutions for Molnupiravir
The following data is based on the product molecular weight 329.31. Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which will affect the solvent volumes required to prepare stock solutions.
|Concentration / Solvent Volume / Mass||1 mg||5 mg||10 mg|
|1 mM||3.04 mL||15.18 mL||30.37 mL|
|5 mM||0.61 mL||3.04 mL||6.07 mL|
|10 mM||0.3 mL||1.52 mL||3.04 mL|
|50 mM||0.06 mL||0.3 mL||0.61 mL|
References for Molnupiravir
References are publications that support the biological activity of the product.
Toots et al (2019) Characterization of orally efficacious influenza drug with high resistance barrier in ferrets and human airway epithelia. Sci.Transl.Med. 11 eaax5866 PMID: 31645453
Sheahan et al (2020) An orally bioavailable broad-spectrum antiviral inhibits SARS-CoV-2 in human airway epithelial cell cultures and multiple coronaviruses in mice. Sci.Transl.Med. 12 eabb5883 PMID: 32253226
Gordon et al (2021) Molnupiravir promotes SARS-CoV-2 mutagenesis via the RNA template. J.Biol.Chem. 297 100770 PMID: 33989635
If you know of a relevant reference for Molnupiravir, please let us know.
View Related Products by Target
Keywords: Molnupiravir, Molnupiravir supplier, broad-spectrum, antiviral, prodrug, nucleoside, analogue, analog, SARS-CoV-2, SARS-CoV, MERS-CoV, inhibitors, inhibits, DNA,, RNA, and, Protein, Synthesis, Coronavirus, Polymerase, 7586, Tocris Bioscience
Citations for Molnupiravir
Citations are publications that use Tocris products.
Currently there are no citations for Molnupiravir. Do you know of a great paper that uses Molnupiravir from Tocris? Please let us know.
Reviews for Molnupiravir
There are currently no reviews for this product. Be the first to review Molnupiravir and earn rewards!
Have you used Molnupiravir?
Submit a review and receive an Amazon gift card.
$50/€35/£30/$50CAN/¥300 Yuan/¥5000 Yen for first to review with an image
$25/€18/£15/$25CAN/¥75 Yuan/¥1250 Yen for a review with an image
$10/€7/£6/$10 CAD/¥70 Yuan/¥1110 Yen for a review without an image
Literature in this Area
Tocris offers the following scientific literature in this area to showcase our products. We invite you to request* your copy today!
*Please note that Tocris will only send literature to established scientific business / institute addresses.
Cell Cycle and DNA Damage Research Product Guide
This product guide provides a review of the cell cycle and DNA damage research area and lists over 170 products, including research tools for:
- Cell Cycle and Mitosis
- DNA Damage Repair
- Targeted Protein Degradation
- Ubiquitin Proteasome Pathway
- Chemotherapy Targets
Huntington's Disease Research Product Guide
This product guide provides a background to Huntington's disease research and lists around 100 products for the study of:
- Somatic Instability
- Proteolysis and Inclusion Bodies
- Transcriptional Dysregulation
- Mitochondrial Dysfunction
- Nuclear-Cytoplasmic Transport Interference
- Stem Cells